Conservest Capital Advisors Inc. Buys 7,772 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Conservest Capital Advisors Inc. increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 23.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 40,813 shares of the exchange traded fund’s stock after purchasing an additional 7,772 shares during the quarter. SPDR S&P Biotech ETF makes up approximately 0.4% of Conservest Capital Advisors Inc.’s investment portfolio, making the stock its 27th biggest position. Conservest Capital Advisors Inc. owned approximately 0.05% of SPDR S&P Biotech ETF worth $3,873,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of XBI. Affinity Asset Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 105.4% in the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after purchasing an additional 737,550 shares during the period. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the period. Mirae Asset Securities USA Inc. bought a new position in SPDR S&P Biotech ETF in the 2nd quarter worth $55,626,000. Jane Street Group LLC increased its stake in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after buying an additional 391,333 shares in the last quarter. Finally, Baymount Management LP purchased a new stake in SPDR S&P Biotech ETF in the 1st quarter worth $34,160,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $99.27 on Friday. The firm has a market capitalization of $7.57 billion, a PE ratio of 11.47 and a beta of 1.11. The stock has a fifty day simple moving average of $98.88 and a two-hundred day simple moving average of $94.90. SPDR S&P Biotech ETF has a 52-week low of $64.99 and a 52-week high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.